TabletsClinical Overview
Zolpidem Tartrate is an imidazopyridine non-benzodiazepine hypnotic agent. It binds selectively with high affinity to the alpha-1 subunit-containing GABAA receptor subtype (omega-1 receptor) in the brain, sparing alpha-2 and alpha-3 subunits, resulting in potent sleep-inducing action with minimal myorelaxant and anticonvulsant effects. Indicated for short-term treatment of insomnia characterized by difficulties with sleep initiation.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally as a single dose immediately before bedtime, ensuring at least 7 to 8 hours remain before waking. Take on an empty stomach for rapid sleep induction. Prescribed strictly for short-term use (7-14 days).
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Dizziness, drowsiness, headache, nausea, diarrhea, fatigue, dry mouth. Rare/Severe: Black box warning: Complex sleep behaviors (sleepwalking, sleep-driving, making phone calls while asleep), severe depression/suicidality, and next-day psychomotor impairment.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Black box warning for dangerous complex sleep behaviors; discontinue treatment permanently if an episode occurs. In women and the elderly, lower starting doses (5 mg) are recommended due to slower drug clearance. Avoid alcohol.
Schedule H1 (Prescription Required - Habit Forming Warning)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Zolpidem Tablets 5mg
Zolpidem Tartrate is an imidazopyridine non-benzodiazepine hypnotic agent. It binds selectively with high affinity to the alpha-1 subunit-containing GABAA receptor subtype (omega-1 receptor) in the brain, sparing alpha-2 and alpha-3 subunits, resulting in potent sleep-inducing action with minimal myorelaxant and anticonvulsant effects. Indicated for short-term treatment of insomnia characterized by difficulties with sleep initiation.
Melatonin + Zolpidem Tablet (3/10 Mg)
Zolpidem and Melatonin is a dual-mechanism sleep regulator combining a non-benzodiazepine positive allosteric modulator with the endogenous pineal chronobiotic hormone. Zolpidem binds selectively to the alpha-1 subunit of the GABAA receptor, rapidly inducing sleep onset within 15-30 minutes, while melatonin acts on MT1 and MT2 receptors in the suprachiasmatic nucleus to synchronize circadian sleep architecture and promote restful sleep maintenance. Indicated for short-term management of sleep-onset and sleep-maintenance insomnia and jet lag/circadian rhythm sleep disorders.
Melatonin + Zolpidem Tablet (3/5 Mg)
Zolpidem and Melatonin is a dual-mechanism sleep regulator combining a non-benzodiazepine positive allosteric modulator with the endogenous pineal chronobiotic hormone. Zolpidem binds selectively to the alpha-1 subunit of the GABAA receptor, rapidly inducing sleep onset within 15-30 minutes, while melatonin acts on MT1 and MT2 receptors in the suprachiasmatic nucleus to synchronize circadian sleep architecture and promote restful sleep maintenance. Indicated for short-term management of sleep-onset and sleep-maintenance insomnia and jet lag/circadian rhythm sleep disorders.